Work

Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome

Year: 2019
Type: review
Abstract: Sepsis-induced acute respiratory distress syndrome (ARDS) has high morbidity and mortality and arises after lung infection or infection at extrapulmonary sites. An aberrant host response to infection leads to disruption of the pulmonary alveolar-capillary barrier, resulting in lung injury characterized by hypoxemia, inflammation, and noncardiogenic pulmonary edema. Despite increased understanding of the molecular biology underlying sepsis-induced ARDS, there are no targeted pharmacologic therapies for this devastating condition. Here, we review the molecular underpinnings of sepsis-induced ARDS with a focus on relevant clinical and translational studies that point toward novel therapeutic strategies.
Source: JCI Insight
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,100
OpenAlex ID: W2913810523
FWCI: 3.884
Cites: 158
Cited by: 225
Related to: 10